SpectraScience Inc. (SCIE) Financials Nov 14, 2014
Post# of 250675
Posted On: 11/17/2014 2:35:02 AM
SpectraScience Inc. (SCIE) Financials Nov 14, 2014, 8:10 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for SpectraScience Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 167,123 23,650 26,735 461,296 240,000
Cost of Goods Sold (COGS) incl. D&A 401,081 334,046 335,618 1.23M 364,695
COGS excluding D&A 110,572 13,277 37,455 313,069 125,395
Depreciation & Amortization Expense 290,509 320,769 298,163 916,798 239,300
Depreciation 40,509 70,000 64,000 163,000 73,853
Amortization of Intangibles 250,000 250,769 234,163 753,798 165,447
Gross Income (233,958) (310,396) (308,883) (768,571) (124,695)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.2M 3.12M 4.46M 3.55M 2.61M
Research & Development 2.13M 1.04M 1.68M 1.11M 644,076
Other SG&A 2.08M 2.08M 2.78M 2.44M 1.96M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 1.03M 0 820,324 (2.29M)
EBIT after Unusual Expense 0 (1.03M) 0 (820,324) 2.29M
Non Operating Income/Expense 4,625 359,104 5,480 (882) (9,597)
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 0 0 0 3.95M 2.29M
Gross Interest Expense 0 0 0 3.95M 2.29M
Interest Capitalized 0 0 0 0 0
Pretax Income (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Minority Interest Expense 0 0 0 0 0
Net Income (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Preferred Dividends 2.69M 1.94M 0 0 0
Net Income Available to Common (7.12M) (6.04M) (4.76M) (9.09M) (2.75M)
EPS (Basic) (0.10) (0.07) (0.04) (0.08) (0.02)
Basic Shares Outstanding 69.78M 92.45M 108.04M 118.76M 160.02M
EPS (Diluted) (0.10) (0.07) (0.04) (0.09) (0.02)
Diluted Shares Outstanding 69.78M 92.45M 108.04M 132.28M 160.02M
EBITDA (4.15M) (3.11M) (4.47M) (3.4M) (2.49M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for SpectraScience Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 167,123 23,650 26,735 461,296 240,000
Cost of Goods Sold (COGS) incl. D&A 401,081 334,046 335,618 1.23M 364,695
COGS excluding D&A 110,572 13,277 37,455 313,069 125,395
Depreciation & Amortization Expense 290,509 320,769 298,163 916,798 239,300
Depreciation 40,509 70,000 64,000 163,000 73,853
Amortization of Intangibles 250,000 250,769 234,163 753,798 165,447
Gross Income (233,958) (310,396) (308,883) (768,571) (124,695)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 4.2M 3.12M 4.46M 3.55M 2.61M
Research & Development 2.13M 1.04M 1.68M 1.11M 644,076
Other SG&A 2.08M 2.08M 2.78M 2.44M 1.96M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 1.03M 0 820,324 (2.29M)
EBIT after Unusual Expense 0 (1.03M) 0 (820,324) 2.29M
Non Operating Income/Expense 4,625 359,104 5,480 (882) (9,597)
Non-Operating Interest Income - - - 0 0
Equity in Affiliates (Pretax) 0 0 0 0 -
Interest Expense 0 0 0 3.95M 2.29M
Gross Interest Expense 0 0 0 3.95M 2.29M
Interest Capitalized 0 0 0 0 0
Pretax Income (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Income Tax 0 0 0 0 0
Income Tax - Current Domestic 0 0 0 - -
Income Tax - Current Foreign 0 0 0 - -
Income Tax - Deferred Domestic 0 0 0 - -
Income Tax - Deferred Foreign 0 0 0 - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Minority Interest Expense 0 0 0 0 0
Net Income (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.43M) (4.1M) (4.76M) (9.09M) (2.75M)
Preferred Dividends 2.69M 1.94M 0 0 0
Net Income Available to Common (7.12M) (6.04M) (4.76M) (9.09M) (2.75M)
EPS (Basic) (0.10) (0.07) (0.04) (0.08) (0.02)
Basic Shares Outstanding 69.78M 92.45M 108.04M 118.76M 160.02M
EPS (Diluted) (0.10) (0.07) (0.04) (0.09) (0.02)
Diluted Shares Outstanding 69.78M 92.45M 108.04M 132.28M 160.02M
EBITDA (4.15M) (3.11M) (4.47M) (3.4M) (2.49M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
(0)
(0)